Breaking News Instant updates and real-time market news.

UROV

Urovant Sciences

$7.29

-0.33 (-4.33%)

16:06
08/13/19
08/13
16:06
08/13/19
16:06

Urovant Sciences reports Q1 EPS (94c), consensus ($1.08)

As of June 30, 2019, total cash and cash equivalents was $62.4 million or $92.4 million with the $30 million available to be drawn down from Hercules Capital by September 30, 2019. "During the last quarter, Urovant Sciences continued to make excellent progress towards its vision of becoming a leading specialty urology company," said Keith A. Katkin, chief executive officer of Urovant. "Today, we are very pleased to announce the successful completion of the vibegron ambulatory blood pressure study. This study will be an important component of our NDA and further supports the favorable safety profile of vibegron. We also remain on schedule to report results for the long-term extension portion of the phase 3 EMPOWUR study by the end of this quarter and are well underway in preparing to file the vibegron NDA by early 2020."

  • 13

    Aug

UROV Urovant Sciences
$7.29

-0.33 (-4.33%)

03/15/19
03/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Simmons First National (SFNC) initiated with a Buy at DA Davidson. 2. Amgen (AMGN) and Gilead (GILD) initiated with an Outperform at BMO Capital. 3. Rocket Pharmaceuticals (RCKT) initiated with a Buy at BofA/Merrill. 4. Urovant Sciences (UROV) initiated with a Buy at SunTrust. 5. Spectrum (SPPI) assumed with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
JPMS
03/20/19
NO CHANGE
Target $24
JPMS
Overweight
JPMorgan boosts Urovant target to $24, calls selloff yesterday unfounded
JPMorgan analyst Eric Joseph raised his price target for Urovant Sciences to $24 from $20 saying he views the Empowur data, "showing clear and early separation from placebo across all primary and secondary endpoints, as a key de-risking event for the program." The data support "best-in-class commercial" for vibegron in overactive bladder, Joseph tells investors in a research note. The analyst views yesterday's stock pullback as unfounded and sees an attractive entry point at current share levels. He keeps an Overweight rating on Urovant Sciences.
03/20/19
COWN
03/20/19
NO CHANGE
Target $25
COWN
Outperform
Urovant's vibegron data present clear path to approval, says Cowen
After Urovant Sciences announced top-line results from the Phase 3 study of Vibegron in adults with overactive bladder, Cowen analyst Ritu Baral called the results "extremely positive" and contends they present a clear path to approval. She also believes the data set up a "compelling marketing strategy" built around a superior clinical profile, Baral tells investors. She maintains an Outperform rating on Urovant shares with a $25 price target.
06/14/19
JPMS
06/14/19
NO CHANGE
Target $24
JPMS
Overweight
Urovant Sciences continued share weakness unwarranted, says JPMorgan
JPMorgan analyst Eric Joseph keeps an Overweight rating on Urovant Sciences with a $24 price target following the company's Q4 results. The analyst continues to view vibegron as a "best-in-class" beta-3 agonist. As such, the continued weakness in Urovant Sciences is unwarranted and "under reflects" the vibegron commercial opportunity, with label expansion programs as "virtual free call options," Joseph tells investors in a research note.

TODAY'S FREE FLY STORIES

TACO

Del Taco

$10.90

-0.13 (-1.18%)

11:49
08/20/19
08/20
11:49
08/20/19
11:49
Periodicals
Del Taco said to hire bankers to consider sale, blog report claims »

Del Taco Restaurants has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 04

    Nov

FB

Facebook

$184.89

-1.33 (-0.71%)

11:44
08/20/19
08/20
11:44
08/20/19
11:44
Periodicals
Executive says Facebook new privacy feature may dent revenue, Bloomberg reports »

Facebook finished a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

M

Macy's

$15.70

-0.43 (-2.67%)

11:40
08/20/19
08/20
11:40
08/20/19
11:40
Options
Short-term put buyer as Macy's hits new lows »

Short-term put buyer as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MA

MasterCard

$279.09

1.05 (0.38%)

, GS

Goldman Sachs

$201.86

-0.35 (-0.17%)

11:34
08/20/19
08/20
11:34
08/20/19
11:34
Hot Stocks
Apple launches Apple Card for U.S. customers »

Apple Card, a credit card…

MA

MasterCard

$279.09

1.05 (0.38%)

GS

Goldman Sachs

$201.86

-0.35 (-0.17%)

UBER

Uber

$35.81

1.23 (3.56%)

AAPL

Apple

$212.98

2.66 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 27

    Oct

BYND

Beyond Meat

$155.67

11.23 (7.77%)

, HAIN

Hain Celestial

$19.80

-2.08 (-9.51%)

11:31
08/20/19
08/20
11:31
08/20/19
11:31
On The Fly
Beyond Meat upgrade, HP downgrade among today's top analyst actions »

Check out today's top…

BYND

Beyond Meat

$155.67

11.23 (7.77%)

HAIN

Hain Celestial

$19.80

-2.08 (-9.51%)

HPQ

HP Inc.

$19.06

-0.16 (-0.83%)

ABBV

AbbVie

$67.39

0.84 (1.26%)

PPC

Pilgrim's Pride

$30.60

1.45 (4.97%)

SQ

Square

$64.52

0.41 (0.64%)

PYPL

PayPal

$108.44

0.8 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 09

    Sep

  • 10

    Sep

  • 15

    Sep

  • 16

    Sep

  • 25

    Sep

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

HGV

Hilton Grand Vacations

$31.11

2.905 (10.30%)

, APO

Apollo Global

$34.24

0.55 (1.63%)

11:29
08/20/19
08/20
11:29
08/20/19
11:29
Recommendations
Hilton Grand Vacations, Apollo Global, Blackstone analyst commentary at Goldman Sachs »

Potential consolidation…

HGV

Hilton Grand Vacations

$31.11

2.905 (10.30%)

APO

Apollo Global

$34.24

0.55 (1.63%)

BX

Blackstone

$48.70

0.85 (1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AAPL

Apple

$213.03

2.71 (1.29%)

11:29
08/20/19
08/20
11:29
08/20/19
11:29
Periodicals
Apple's health team sees departures as tension brews over direction, CNBC says »

Apple's health team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLEX

Flex

$10.05

0.02 (0.20%)

11:25
08/20/19
08/20
11:25
08/20/19
11:25
Conference/Events
Flex to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

SIG

Signet Jewelers

$11.88

-0.45 (-3.65%)

11:20
08/20/19
08/20
11:20
08/20/19
11:20
Options
Put seller smacks bid for 2K Jan 10 puts in Signet Jewelers »

Put seller smacks bid for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

11:20
08/20/19
08/20
11:20
08/20/19
11:20
General news
Treasury announced $95 B in 4- and 8-week bills for Thursday »

Treasury announced $95 B…

TJX

TJX

$50.31

-1.24 (-2.41%)

11:19
08/20/19
08/20
11:19
08/20/19
11:19
Earnings
Breaking Earnings news story on TJX 

TJX sees Q4 EPS 74c-77c

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.32

-1.23 (-2.39%)

11:19
08/20/19
08/20
11:19
08/20/19
11:19
Earnings
TJX sees FY20 revenue $40.9B-$41.2B, consensus $41.33B »

Sees FY20 Marmaxx comp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.30

-1.25 (-2.42%)

11:18
08/20/19
08/20
11:18
08/20/19
11:18
Earnings
Breaking Earnings news story on TJX »

TJX sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TRMD

TORM A/S

$7.10

(0.00%)

11:17
08/20/19
08/20
11:17
08/20/19
11:17
Hot Stocks
Breaking Hot Stocks news story on TORM A/S »

TORM PLC (Class A Stock)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/20/19
08/20
11:17
08/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$50.16

-1.39 (-2.70%)

11:17
08/20/19
08/20
11:17
08/20/19
11:17
Earnings
Breaking Earnings news story on TJX »

TJX sees Marshall's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.16

-1.395 (-2.71%)

11:16
08/20/19
08/20
11:16
08/20/19
11:16
Hot Stocks
TJX sees buying back approximately $1.75B of TJX stock for FY20 »

Comments taken from Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/20/19
08/20
11:16
08/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VUZI

Vuzix

$1.88

-0.08 (-4.08%)

11:15
08/20/19
08/20
11:15
08/20/19
11:15
Hot Stocks
Vuzix receives follow-on Smart Glasses order from 1Minuut Innovation »

Vuzix Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$50.15

-1.4 (-2.72%)

11:14
08/20/19
08/20
11:14
08/20/19
11:14
Hot Stocks
Breaking Hot Stocks news story on TJX »

TJX saw small impact due…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.15

-1.4 (-2.72%)

11:13
08/20/19
08/20
11:13
08/20/19
11:13
Hot Stocks
Breaking Hot Stocks news story on TJX »

TJX CEO says feels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TRMD

TORM A/S

$7.10

(0.00%)

11:12
08/20/19
08/20
11:12
08/20/19
11:12
Hot Stocks
Breaking Hot Stocks news story on TORM A/S »

TORM PLC (Class A Stock)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZUO

Zuora

$13.60

-0.065 (-0.48%)

11:08
08/20/19
08/20
11:08
08/20/19
11:08
Earnings
Zuora appoints new Chief Product Officer, Chief Customer Officer »

Zuora (ZUO) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Sep

FB

Facebook

$184.95

-1.27 (-0.68%)

11:08
08/20/19
08/20
11:08
08/20/19
11:08
Hot Stocks
Facebook announces new tool for users' data control »

Facebook announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

11:08
08/20/19
08/20
11:08
08/20/19
11:08
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.